Systematic Development of National Guidelines for Obesity Care: The Swedish Approach

Obes Facts. 2024;17(2):183-190. doi: 10.1159/000536320. Epub 2024 Jan 22.

Abstract

Introduction: With the rapid development of treatment modalities for obesity management, there is an increasing demand for guidance to facilitate the prioritization of interventions. In 2020, the Swedish National Board of Health and Welfare started the process of producing the first national guidelines for obesity care directed to decision makers who allocate resources to the best knowledge-based care. The main aim of this paper was to describe the systematic development of these guidelines, designed to guarantee uniformly high standards of care throughout the whole country.

Methods: The standardized procedures of the National Board of Health and Welfare were applied to construct guidelines in a systematic and transparent way, including priority setting of recommendations and quality indicators to evaluate the progress of implementation. The process involved independent expert committees including professionals and patient representatives, and the guidelines were reviewed through an open public consultation.

Results: National guidelines were issued in 2023, encompassing a broad scope, from identification and diagnosis to multiple treatment modalities, embedded in a life-course perspective from pregnancy to the elderly, as well as highlighting the need for improved knowledge and competence of health care providers.

Conclusions: National guidelines for improved standard care and evidence-based and efficient use of health care resources for obesity treatment can be developed in a systematic way with professionals and patient representatives.

Keywords: Adult; Bariatric surgery; Child; Disease management; GRADE approach; Guideline; Health care; Obesity; Policy; Quality indicators.

MeSH terms

  • Aged
  • Female
  • Humans
  • Obesity / therapy
  • Obesity Management*
  • Pregnancy
  • Sweden

Grants and funding

This research did not receive grants from any funding agency in the public, commercial, or not-for-profit sectors. L.S. received Grants from Sahlgrenska University Hospital and Y.T.L. received grants from the Stockholm County Council (clinical research appointment). Funding bodies had no influence on the content of the guideline.